6 Einträge gefunden

1. [Beta blockers in cardiac insufficiency. When, how much and which substance]

   1. Wuttke, Henrike
   2. Rau, Thomas
   3. Eschenhagen, Thomas

   2004 - Forschungsinformationssystem des UKE
2. CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.

   1. Rau, Thomas
   2. Wohlleben, Gerlinde
   3. Wuttke, Henrike
   4. Thuerauf, Norbert
   5. Lunkenheimer, Jens
   6. Lanczik, Mario
   7. Eschenhagen, Thomas

   2004 - Forschungsinformationssystem des UKE
3. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.

   1. Keller, Dagmar I
   2. Coirault, Catherine
   3. Rau, Thomas
   4. Cheav, Theary
   5. Weyand, Michael
   6. Amann, Kerstin
   7. Lecarpentier, Yves

   2004 - Forschungsinformationssystem des UKE
4. Formation of molecular complexes by N-methyl-D-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocard.

   1. Seeber, Silke
   2. Humeny, Andreas
   3. Herkert, Matthias
   4. Rau, Thomas
   5. Eschenhagen, Thomas
   6. Becker, Cord-Michael

   2004 - Forschungsinformationssystem des UKE
5. Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts.

   1. El-Armouche, Ali
   2. Jaeckel, Elmar
   3. Boheler, Kenneth R
   4. Boknik, Peter
   5. Hertle, Boris
   6. Neumann, Joachim
   7. Eschenhagen, Thomas

   2004 - Forschungsinformationssystem des UKE
6. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.

   1. El-Armouche, Ali
   2. Pamminger, Torsten
   3. Ditz, Diana
   4. Zolk, Oliver
   5. Eschenhagen, Thomas

   2004 - Forschungsinformationssystem des UKE